百度智能雲簽約28家生態夥伴
百度(09888.HK)(BIDU.US)旗下百度智能雲近日舉行2023百度智能雲合作夥伴大會,會上簽約28家生態夥伴,當中包括10家文心千帆生態夥伴。目前已有超過300家夥伴參與文心千帆大模型平台內測,在400多個企業內部場景取得測試成效。
公司指,未來將與合作夥伴攜手探索文心千帆大模型平台在各領域的創新應用,並將合力打造數字化轉型與智能化升級的一站式產品、方案和服務。
集團副總裁袁佛玉表示,大模型時代會帶來新型雲計算、行業模型精調、應用開發共三大產業機會,客戶和夥伴無論希望在這三層的哪一層投入,百度智能雲都能提供所需的可靠服務,包括全球首個一站式企業級大模型生產平台文心千帆、全棧自研的AI時代基礎設施百度AI大底座。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.